119 related articles for article (PubMed ID: 32948632)
1. Association between Receipt of Guideline-Concordant Lung Cancer Treatment and Individual- and Area-Level Factors: A Spatio-Temporal Analysis.
Wah W; Stirling RG; Ahern S; Earnest A
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2669-2679. PubMed ID: 32948632
[TBL] [Abstract][Full Text] [Related]
2. Influence of timeliness and receipt of first treatment on geographic variation in non-small cell lung cancer mortality.
Wah W; Stirling RG; Ahern S; Earnest A
Int J Cancer; 2021 Apr; 148(8):1828-1838. PubMed ID: 33045098
[TBL] [Abstract][Full Text] [Related]
3. A multi-level spatio-temporal analysis on prostate cancer outcomes.
Wah W; Papa N; Evans M; Ahern S; Earnest A
Cancer Epidemiol; 2021 Jun; 72():101939. PubMed ID: 33862413
[TBL] [Abstract][Full Text] [Related]
4. Association of area-level mortgage denial and guideline-concordant non-small-cell lung cancer care and outcomes in the United States.
Fan Q; Hussaini SMQ; Barrow LCJ; Feliciano JL; Pollack CE; Yabroff KR; Nogueira L
Cancer Med; 2024 Feb; 13(3):e6921. PubMed ID: 38205942
[TBL] [Abstract][Full Text] [Related]
5. Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.
Nicoli CD; Sprague BL; Anker CJ; Lester-Coll NH
Am J Clin Oncol; 2019 Jul; 42(7):607-614. PubMed ID: 31232724
[TBL] [Abstract][Full Text] [Related]
6. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
[TBL] [Abstract][Full Text] [Related]
7. Application of Guideline Recommended Treatment in Routine Clinical Practice: A Population-based Study of Stage I-IIIB Non-small Cell Lung Cancer.
Duggan KJ; Descallar J; Vinod SK
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):639-47. PubMed ID: 27211609
[TBL] [Abstract][Full Text] [Related]
8. The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study.
Forrest LF; Adams J; Rubin G; White M
Thorax; 2015 Feb; 70(2):138-45. PubMed ID: 24923873
[TBL] [Abstract][Full Text] [Related]
9. Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer.
Stokes SM; Massarweh NN; Stringham JR; Varghese TK
Ann Thorac Surg; 2019 Sep; 108(3):837-844. PubMed ID: 31026431
[TBL] [Abstract][Full Text] [Related]
10. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.
Johnson AM; Hines RB; Johnson JA; Bayakly AR
Lung Cancer; 2014 Mar; 83(3):401-7. PubMed ID: 24491311
[TBL] [Abstract][Full Text] [Related]
11. The impact of patient travel time on disparities in treatment for early stage lung cancer in California.
Obrochta CA; Parada H; Murphy JD; Nara A; Trinidad D; Araneta MRH; Thompson CA
PLoS One; 2022; 17(10):e0272076. PubMed ID: 36197902
[TBL] [Abstract][Full Text] [Related]
12. Inferring lung cancer risk factor patterns through joint Bayesian spatio-temporal analysis.
Cramb SM; Baade PD; White NM; Ryan LM; Mengersen KL
Cancer Epidemiol; 2015 Jun; 39(3):430-9. PubMed ID: 25805551
[TBL] [Abstract][Full Text] [Related]
13. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
14. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
[TBL] [Abstract][Full Text] [Related]
15. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
16. Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage.
Dasgupta P; Baade PD; Aitken JF; Turrell G
Breast Cancer Res Treat; 2012 Apr; 132(2):701-10. PubMed ID: 22160639
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Yorio JT; Yan J; Xie Y; Gerber DE
Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
[TBL] [Abstract][Full Text] [Related]
18. Neighborhood context and non-small cell lung cancer outcomes in Florida non-elderly patients by race/ethnicity.
Johnson AM; Johnson A; Hines RB; Mohammadi R
Lung Cancer; 2020 Apr; 142():20-27. PubMed ID: 32062478
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non-small cell lung cancer 2007-2016.
Shah M; Parmar A; Chan KKW
Cancer Med; 2020 May; 9(10):3407-3416. PubMed ID: 32196964
[TBL] [Abstract][Full Text] [Related]
20. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer.
Toubat O; Atay SM; Kim AW; Ding L; Farias AJ; Ebner PJ; McFadden PM; David EA
Ann Thorac Surg; 2020 May; 109(5):1512-1520. PubMed ID: 31982443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
